How the 2026/27 Australian Federal Budget Will Benefit the Emerging Biotech Industry
The Federal Budget announced last night has introduced several major reforms to the Australian R&D Tax Incentive (RDTI) program, creating […]
CMC Services
Overcoming Solubility Challenges in Early-Phase Drug Formulation
Poor solubility is one of the most common challenges encountered during early-stage drug development. When an active pharmaceutical ingredient (API)
Preparing for an Analytical Audit: What Pharma Companies Need to Know
Analytical audits play a critical role in ensuring pharmaceutical products meet regulatory standards for safety, quality, and consistency. Being prepared
Immediate vs Modified Release Formulations: What’s Right for Your Drug Candidate?
When developing a new drug product, choosing the right release profile is critical. Immediate and modified release formulations offer distinct
The Role of CMC in Drug Development: Why It’s Critical for Regulatory Success
Ensuring the quality, safety, and efficacy of pharmaceutical products is essential for gaining regulatory approval and bringing a new drug
